Brain CB1 receptor expression following lipopolysaccharide-induced inflammation

Neuroscience

Volumn 227, Issue , 2012, Pages 211-222

  Hu, H ^a,b   Ho, W ^a   Mackie, K ^c   Pittman, Q J ^a   Sharkey, K A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Cannabinoids; Hippocampus; Lipopolysaccharide; Microglial cells

Indexed keywords

CANNABINOID 1 RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; ENCEPHALITIS; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOOD DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER; TIME FACTORS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 84868240366     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.067     Document Type: Article

References (54)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001, 2:734-744.
2. Basavarajappa B.S., Hungund B.L. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Prostaglandins Leukot Essent Fatty Acids 2002, 66:287-299.
3. Beishuizen A., Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 2003, 9:3-24.
4. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog Brain Res 2007, 162:3-14.
5. Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 1999, 73:2447-2459.
6. Buijs R.M., van der Vliet J., Garidou M.L., Huitinga I., Escobar C. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One 2008, 3:e3152.
7. Chung D.W., Yoo K.Y., Hwang I.K., Kim D.W., Chung J.Y., Lee C.H., Choi J.H., Choi S.Y., Youn H.Y., Lee I.S., Won M.H. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell Mol Neurobiol 2010, 30:531-541.
8. Coutts A.A., Anavi-Goffer S., Ross R.A., MacEwan D.J., Mackie K., Pertwee R.G., Irving A.J. Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci 2001, 21:2425-2433.
9. Cristino L., De Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
10. Crosby K.M., Inoue W., Pittman Q.J., Bains J.S. Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron 2011, 71:529-541.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
12. Day H.E., Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology 1996, 63:207-218.
13. De Laurentiis A., Fernandez-Solari J., Mohn C., Burdet B., Zorrilla Zubilete M.A., Rettori V. The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide. J Neuroimmunol 2010, 221:32-41.
14. Fraga D., Zanoni C.I., Rae G.A., Parada C.A., Souza G.E. Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol 2009, 157:1494-1501.
15. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego.
16. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
17. Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front Neuroendocrinol 2012, 33:116-125.
18. Hajos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000, 12:3239-3249.
19. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997, 20:78-84.
20. Hill M.N., Gorzalka B.B. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol Disord Drug Targets 2009, 8:451-458.
21. Hill M.N., Hunter R.G., McEwen B.S. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields. Eur J Pharmacol 2009, 614:66-69.
22. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
23. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996, 224:855-862.
24. Jorge R.E., Acion L., Starkstein S.E., Magnotta V. Hippocampal volume and mood disorders after traumatic brain injury. Biol Psychiatry 2007, 62:332-338.
25. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
26. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol Rev 2011, 91:461-553.
27. Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev 2005, 48:196-206.
28. Manders E.M.M., Verbeek F.J., Aten J.A. Measurement of co-localization of objects in dual-colour confocal images. J Microsc 1993, 169:375-382.
29. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
30. Martin B.R., Sim-Selley L.J., Selley D.E. Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 2004, 25:325-330.
31. Martini L., Waldhoer M., Pusch M., Kharazia V., Fong J., Lee J.H., Freissmuth C., Whistler J.L. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. FASEB J 2007, 21:802-811.
32. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun 2004, 18:123-134.
33. McKinney D.L., Cassidy M.P., Collier L.M., Martin B.R., Wiley J.L., Selley D.E., Sim-Selley L.J. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 2008, 324:664-673.
34. Nomura D.K., Morrison B.E., Blankman J.L., Long J.Z., Kinsey S.G., Marcondes M.C.G., Ward A.M., Hahn Y.K., Lichtman A.H., Conti B., Cravatt B.F. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 2011, 33:809-813.
35. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 2002, 3:216-227.
36. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 2009, 29:4200-4209.
37. Park S.M., Gaykema R.P., Goehler L.E. How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry. Brain Behav Immun 2008, 22:1160-1172.
38. Parolaro D., Realini N., Vigano D., Guidali C., Rubino T. The endocannabinoid system and psychiatric disorders. Exp Neurol 2010, 224:3-14.
39. Riazi K., Galic M.A., Kuzmiski J.B., Ho W., Sharkey K.A., Pittman Q.J. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 2008, 105:17151-17156.
40. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 2003, 17:13-19.
41. Romero J., Berrendero F., Manzanares J., Perez A., Corchero J., Fuentes J.A., Fernandez-Ruiz J.J., Ramos J.A. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse 1998, 30:298-308.
42. Sagar S.M., Price K.J., Kasting N.W., Sharp F.R. Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res Bull 1995, 36:381-392.
43. Sim-Selley L.J. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 2003, 15:91-119.
44. Sim-Selley L.J., Schechter N.S., Rorrer W.K., Dalton G.D., Hernandez J., Martin B.R., Selley D.E. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol Pharmacol 2006, 70:986-996.
45. Smith T.H., Sim-Selley L.J., Selley D.E. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?. Br J Pharmacol 2010, 160:454-466.
46. Solinas M., Yasar S., Goldberg S.R. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res 2007, 56:393-405.
47. Steiner A.A., Molchanova A.Y., Dogan M.D., Patel S., Petervari E., Balasko M., Wanner S.P., Eales J., Oliveira D.L., Gavva N.R., Almeida M.C., Szekely M., Romanovsky A.A. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors. J Physiol 2011, 589:2415-2431.
48. Storr M.A., Keenan C.M., Zhang H., Patel K.D., Makriyannis A., Sharkey K.A. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 2009, 15:1678-1685.
49. Straiker A., Wager-Miller J., Mackie K. The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones. Br J Pharmacol 2012, 165:2652-2659.
50. Suarez J., Bermudez-Silva F.J., Mackie K., Ledent C., Zimmer A., Cravatt B.F., De Fonseca F.R. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol 2008, 509:400-421.
51. Suarez J., Romero-Zerbo S.Y., Rivera P., Bermudez-Silva F.J., Perez J., De Fonseca F.R., Fernandez-Llebrez P. Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study. J Comp Neurol 2010, 518:3065-3085.
52. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
53. Van Sickle M.D., Oland L.D., Mackie K., Davison J.S., Sharkey K.A. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 2003, 285:G566-G576.
54. Wang M., Hill M.N., Zhang L., Gorzalka B.B., Hillard C.J., Alger B.E. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol 2012, 26:56-70.